Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Borbath

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Targeted Oncology|May 20, 2016
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of EverolimusMarianne Pavel, Nicole Unger, Ivan Borbath, et al.
BMC Cancer|September 22, 2023
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trialChristelle Bouchart, Julie Navez, Ivan Borbath, et al.
Acta Clinica Belgica|January 11, 2021
Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)Veerle Casneuf, Ivan Borbath, Marc Van den Eynde, et al.
Frontiers in Medicine|October 29, 2025
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histologyLaurent Meric de Bellefon, Francesco Natalucci, Adrien Nzeusseu Toukap, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 19, 2010
Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature reviewEliano Bonaccorsi-Riani, Carlos Apestegui, Anne Jouret-Mourin, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 8, 2015
Diagnostic and Therapeutic Roles of Endoscopic Ultrasound in Pediatric Pancreaticobiliary DisordersIsabelle Scheers, Meltem Ergun, Tarik Aouattah, et al.
Neuroendocrinology|August 29, 2018
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)Halfdan Sorbye, Eric Baudin, Ivan Borbath, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2021
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study resultsMarianne Pavel, Jaroslaw B Ćwikła, Catherine Lombard-Bohas, et al.
Annals of Nuclear Medicine|September 11, 2012
Significant impact of transient deterioration of renal function on dosimetry in PRRTSofie Van Binnebeek, Kristof Baete, Christelle Terwinghe, et al.
Therapeutic Advances in Medical Oncology|August 21, 2023
A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in BelgiumLise Verbruggen, Lisa Verheggen, Greetje Vanhoutte, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Targeted Oncology|May 20, 2016
Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of EverolimusMarianne Pavel, Nicole Unger, Ivan Borbath, et al.
BMC Cancer|September 22, 2023
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trialChristelle Bouchart, Julie Navez, Ivan Borbath, et al.
Acta Clinica Belgica|January 11, 2021
Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)Veerle Casneuf, Ivan Borbath, Marc Van den Eynde, et al.
Frontiers in Medicine|October 29, 2025
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histologyLaurent Meric de Bellefon, Francesco Natalucci, Adrien Nzeusseu Toukap, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 19, 2010
Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature reviewEliano Bonaccorsi-Riani, Carlos Apestegui, Anne Jouret-Mourin, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 8, 2015
Diagnostic and Therapeutic Roles of Endoscopic Ultrasound in Pediatric Pancreaticobiliary DisordersIsabelle Scheers, Meltem Ergun, Tarik Aouattah, et al.
Neuroendocrinology|August 29, 2018
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)Halfdan Sorbye, Eric Baudin, Ivan Borbath, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2021
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study resultsMarianne Pavel, Jaroslaw B Ćwikła, Catherine Lombard-Bohas, et al.
Annals of Nuclear Medicine|September 11, 2012
Significant impact of transient deterioration of renal function on dosimetry in PRRTSofie Van Binnebeek, Kristof Baete, Christelle Terwinghe, et al.
Therapeutic Advances in Medical Oncology|August 21, 2023
A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in BelgiumLise Verbruggen, Lisa Verheggen, Greetje Vanhoutte, et al.
Pageof 9